Home Jobs Director Network Strategy - New Modalities
Back to Jobs

Director Network Strategy - New Modalities - Job Opportunity at Johnson & Johnson

Zug, Switzerland
Full-time
Executive
Posted: June 17, 2025
Hybrid
USD 180,000 - 250,000 per year plus executive bonus and equity compensation. This executive-level position in biotherapeutics strategy at a Fortune 50 pharmaceutical company, with responsibilities spanning global operations and multi-billion dollar investment decisions, typically commands premium compensation reflecting the strategic importance and specialized expertise required.

Benefits

Comprehensive global healthcare benefits package reflecting Johnson & Johnson's commitment to employee wellness and health innovation
Hybrid work arrangement providing flexibility to balance professional responsibilities with personal needs
Access to cutting-edge biotherapeutic and pharmaceutical research environments at multiple global locations
International career mobility opportunities across Switzerland, United States, Ireland, Belgium, and Netherlands
Professional development programs aligned with Johnson & Johnson's leadership in healthcare innovation
Diversity, equity, and inclusion initiatives supporting career advancement and inclusive workplace culture

Key Responsibilities

Drive enterprise-level network strategy development for biotherapeutic new modalities across drug substance and drug product platforms, directly impacting Johnson & Johnson's competitive position in next-generation therapeutics
Lead cross-functional investment decision processes and portfolio prioritization strategies that shape multi-billion dollar capacity and capability investments across global manufacturing networks
Orchestrate end-to-end supply chain transformation initiatives for emerging biotherapeutic modalities, ensuring Johnson & Johnson maintains technological leadership in advanced therapy manufacturing
Establish strategic partnerships and external network relationships that position the organization at the forefront of biotherapeutic innovation and manufacturing excellence
Direct portfolio rationalization and asset optimization decisions that maximize return on investment while maintaining supply chain resilience for critical patient therapies
Collaborate with R&D leadership to translate scientific pipeline developments into actionable network capacity and capability requirements
Partner with commercial teams to align manufacturing strategy with market access and revenue optimization objectives
Lead crisis management and contingency planning for supply chain disruptions, ensuring continuity of patient access to life-saving therapies

Requirements

Education

A minimum of a bachelor's degree in science, Engineering, Business, or related field. Master's degree in the above subject areas or an MBA is preferred.

Experience

A minimum of ten (10) years combined experience relevant to supply chain

Required Skills

Experience leading large, complex, and interdependent initiatives in a matrix environment Strong analytical, problem-solving, and critical thinking skills Demonstrated ability to translate trends and insights into actional strategies that can be deployed in real-world applications Ability to communicate clearly and concisely across all levels of the company and across our global supply chain Strong business acumen with solid understanding of end-to-end supply chain processes Proven experience in managing against a budget and making decisions that draw upon effective business and financial acumen, including making financial assessments of strategic options and providing recommendations Skills demonstrated in influencing across the matrix and negotiating in situations without positional authority Experience working within different cultures, as well as handling diverse and complex cultural and market-specific issues, such as labor laws, healthcare regulatory requirements, tax law and logistics Detail and solution oriented with ability to work within broad guidelines and exercise considerable initiative, judgment, and decisiveness
Advertisement
Ad Space

Sauge AI Market Intelligence

Industry Trends

The biotherapeutics market is experiencing unprecedented growth driven by advances in cell and gene therapies, personalized medicine, and novel drug delivery systems. Companies are racing to establish manufacturing capabilities for next-generation modalities including CAR-T therapies, gene editing treatments, and complex biologics that require specialized production environments and expertise. Pharmaceutical supply chain resilience has become a critical strategic priority following global disruptions, with companies investing heavily in network diversification, risk mitigation strategies, and flexible manufacturing platforms that can adapt to changing therapeutic landscapes and regulatory requirements. The emergence of precision medicine and patient-specific therapies is fundamentally reshaping manufacturing strategies, requiring more agile, distributed production networks capable of handling smaller batch sizes, customized formulations, and complex cold chain logistics for temperature-sensitive biologics.

Role Significance

This role typically oversees a matrix organization of 50-100 professionals across multiple functions including strategic planning, supply chain engineering, business development, and regional operations teams. The position requires coordination with cross-functional teams spanning R&D, commercial, regulatory, and manufacturing organizations across multiple global sites.
This is a senior executive position reporting directly to C-suite leadership, with significant influence over strategic direction and resource allocation decisions. The role carries enterprise-wide impact on Johnson & Johnson's competitive positioning in the rapidly evolving biotherapeutics market, with responsibility for strategies that affect billions in investment and patient access to life-saving therapies.

Key Projects

Global network optimization initiatives involving facility consolidation, technology transfer, and capacity expansion across multiple therapeutic areas New modality manufacturing strategy development for emerging therapies including cell and gene therapies, requiring specialized facility design and regulatory compliance Strategic partnership evaluations and contract manufacturing organization (CMO) relationship management for complex biotherapeutic production Investment committee presentations and business case development for multi-hundred million dollar manufacturing facility investments

Success Factors

Deep understanding of biotherapeutic manufacturing processes, regulatory requirements, and quality systems is essential for making informed strategic decisions that balance innovation with compliance and patient safety considerations. Exceptional stakeholder management and influence skills are critical for driving consensus across diverse global teams, regulatory bodies, and external partners while navigating complex matrix organizational structures. Strategic thinking capabilities that can synthesize market intelligence, technological trends, and competitive dynamics into actionable network strategies that position the organization for long-term success in emerging therapeutic areas. Financial acumen and business case development expertise to evaluate complex investment scenarios, optimize capital allocation, and demonstrate clear return on investment for large-scale infrastructure decisions.

Market Demand

Extremely high demand driven by the convergence of biotherapeutic innovation, supply chain complexity, and regulatory requirements. The specialized combination of network strategy expertise, biotherapeutic knowledge, and executive leadership capabilities makes this a highly sought-after and scarce skill set in the pharmaceutical industry.

Important Skills

Critical Skills

Strategic planning and business development expertise is absolutely essential for translating market opportunities and technological capabilities into actionable network strategies that drive competitive advantage and patient access to innovative therapies. Cross-functional leadership and matrix management skills are critical for success in Johnson & Johnson's complex organizational environment, requiring the ability to influence without direct authority and build consensus across diverse stakeholder groups with competing priorities. Biotherapeutic manufacturing knowledge and supply chain expertise provide the technical foundation necessary to make informed decisions about capacity investments, technology selection, and operational optimization in highly regulated manufacturing environments. Financial analysis and investment evaluation capabilities are fundamental for developing compelling business cases, optimizing capital allocation, and demonstrating clear return on investment for large-scale infrastructure and technology investments.

Beneficial Skills

Regulatory affairs and compliance expertise enhances the ability to navigate complex global regulatory requirements and anticipate regulatory trends that may impact manufacturing strategy and network design decisions. Digital transformation and Industry 4.0 knowledge provides competitive advantage in leveraging advanced analytics, automation, and digital technologies to optimize supply chain performance and enable more agile manufacturing operations. Mergers and acquisitions experience supports strategic portfolio development and external partnership evaluation, critical capabilities for accessing new technologies and expanding manufacturing capabilities in emerging therapeutic areas. Sustainability and environmental expertise aligns with growing industry focus on green manufacturing practices and helps position Johnson & Johnson as a leader in sustainable pharmaceutical production.

Unique Aspects

This role represents a rare opportunity to shape the future of biotherapeutic manufacturing at global scale, with direct influence over strategic decisions that will impact patient access to breakthrough therapies for serious diseases including cancer, autoimmune disorders, and rare genetic conditions.
The position offers exposure to cutting-edge manufacturing technologies and emerging therapeutic modalities that are reshaping the pharmaceutical industry, including cell and gene therapies, personalized medicine approaches, and novel drug delivery systems.
The role provides unique international experience spanning multiple regulatory environments and cultural contexts, with opportunities to work across Johnson & Johnson's global network of innovation centers and manufacturing facilities in key pharmaceutical hubs.
This position sits at the convergence of multiple high-growth areas including precision medicine, digital health technologies, and sustainable manufacturing practices, offering exposure to transformative trends shaping the future of healthcare delivery.

Career Growth

Progression to C-suite roles typically occurs within 3-5 years for high-performing executives, with opportunities accelerated by successful delivery of major strategic initiatives and demonstrated leadership in navigating complex organizational challenges.

Potential Next Roles

Chief Supply Chain Officer or VP Global Supply Chain at pharmaceutical companies, leading enterprise-wide supply chain transformation and strategic planning initiatives Chief Operating Officer roles at biotech companies or pharmaceutical divisions, with expanded responsibility for manufacturing, quality, and commercial operations Senior Vice President of Operations or Manufacturing at large pharmaceutical companies, overseeing global production networks and operational excellence programs Strategic advisory or consulting roles focused on biotherapeutic manufacturing strategy and supply chain optimization for pharmaceutical and biotech companies

Company Overview

Johnson & Johnson

Johnson & Johnson is the world's largest healthcare company with over $95 billion in annual revenues, leading positions across pharmaceuticals, medical devices, and consumer health products. The company's Innovative Medicine division focuses on breakthrough treatments for serious diseases including oncology, immunology, neuroscience, and rare diseases, with a robust pipeline of next-generation therapies.

Johnson & Johnson maintains the #1 global market position in pharmaceuticals with dominant therapeutic franchises and industry-leading R&D capabilities. The company's financial strength, regulatory expertise, and global infrastructure provide significant competitive advantages in developing and commercializing complex biotherapeutic products requiring substantial investment and specialized manufacturing capabilities.
This role sits at the intersection of Johnson & Johnson's European headquarters operations in Switzerland and its major U.S. manufacturing and R&D centers, providing exposure to global supply chain networks spanning over 60 countries with manufacturing facilities across North America, Europe, and Asia-Pacific regions.
Johnson & Johnson fosters a collaborative, science-driven culture emphasizing patient focus, innovation, and long-term thinking. The company's Credo-based values system promotes ethical decision-making and social responsibility, while its matrix organizational structure encourages cross-functional collaboration and diverse perspectives in strategic planning.
Advertisement
Ad Space
Apply Now

Data Sources & Analysis Information

Job Listings Data

The job listings displayed on this platform are sourced through BrightData's comprehensive API, ensuring up-to-date and accurate job market information.

Sauge AI Market Intelligence

Our advanced AI system analyzes each job listing to provide valuable insights including:

  • Industry trends and market dynamics
  • Salary estimates and market demand analysis
  • Role significance and career growth potential
  • Critical success factors and key skills
  • Unique aspects of each position

This integration of reliable job data with AI-powered analysis helps provide you with comprehensive insights for making informed career decisions.